ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.3523
0.12%
Brent Oil
79.715
0.47%
Bitcoin
69,545.57
-0.16%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo:
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
10/06/202401:00Business WireMedincell publie ses résultats financiers annuels consolidésEU:MEDCLMedincell SA
10/06/202401:00Business WireMedincell Publishes Its Consolidated Annual Financial ResultsEU:MEDCLMedincell SA
10/06/202401:00Business WireQAD kündigt neue KI-Klassifizierungsfunktionen auf dem Gartner® Supply Chain Symposium/Xpo™ 2024 an
10/06/202401:00GlobeNewswire Inc.Regenx Rights Offering Fully SubscribedJ64
10/06/202401:00GlobeNewswire Inc.Shell plc First Quarter 2024 Euro and GBP Equivalent Dividend PaymentsLSE:SHELShell Plc
10/06/202401:00Business WireMilliman Opens Modelling Excellence Center in Madrid
10/06/202401:00GlobeNewswire Inc.Fingerprint Cards AB (publ) will present at Aktiedagarna in Stockholm on June 12, 2024TG:FPQ1Fingerprint Cards AB
10/06/202401:00Business WireQAD dévoile des capacités révolutionnaires de classification par IA au Gartner® Supply Chain Symposium/Xpo™ 2024
10/06/202401:00GlobeNewswire Inc.Subsea7 share repurchasesTG:SOCSubsea 7 SA
10/06/202401:00GlobeNewswire Inc.Distributor Orders Nexstim NBS System 5 for European Hospital
10/06/202400:56PR Newswire (US)J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study
10/06/202400:52Alliance NewsAlliance NewsIsrael war cabinet member quits as Gaza conflict rages
10/06/202400:48Alliance NewsAlliance NewsLONDON MARKET EARLY CALL: Stocks called down ahead of Fed decision
10/06/202400:48Alliance NewsAlliance NewsApple to break AI silence at developers conferenceLSE:0R2VApple Inc
10/06/202400:45Alliance NewsAlliance NewsFar-right EU vote gains rock France with snap election called
10/06/202400:43Alliance NewsAlliance NewsUS in Gaza ceasefire push with UN vote, Middle East tour
10/06/202400:38NEWSBTCTron Price (TRX) Surges Ahead: Leading the Altcoins PackCOIN:ETHUSDEthereum
10/06/202400:33Alliance NewsAlliance NewsGET READY: ME Group International at 0700 BST
10/06/202400:30Alliance NewsAlliance NewsAlliance News UK - start of day
10/06/202400:30GlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
10/06/202400:30Business Wire4Moving Biotech annonce des résultats positifs pour son essai clinique de Phase I Lasare 4P004 liraglutide intra-articulaire sur des patients souffrants d'arthrose du genou
10/06/202400:30GlobeNewswire Inc.Viridien, leader dans les technologies de pointe, lance sa nouvelle marque et accélère sa croissanceEU:VIRIViridien
10/06/202400:30GlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
10/06/202400:30Business Wire4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients
10/06/202400:30GlobeNewswire Inc.Viridien launches new brand to accelerate growth as an advanced technology companyCGG
10/06/202400:30PR Newswire (US)Hozpitality Group Hosts 7th 'Middle East Chef Excellence Awards' at JW Marriott Dubai Marina
10/06/202400:14PR Newswire (US)DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™)
10/06/202400:08NEWSBTCXRP Price Rebound in Jeopardy: Recovery May FalterCOIN:ETHUSDEthereum
10/06/202400:05PR Newswire (US)Build-A-Bear Celebrates International Day of Play with 'The Stuff You Love': Free Lil Cub Bears, Heartwarming Donations and Fun for KidsNYSE:BBWBuild A Bear Workshop Inc
10/06/202400:00GlobeNewswire Inc.IMCD Italy expands its Pharmaceuticals presence with the acquisition of SelechimicaEU:IMCDIMCD NV

Su Consulta Reciente

NASDAQ
MSFT
Microsoft
NYSE
VZ
Verizon Communications
NYSE
CVX
Chevron
AMEX
SPY
SPDR S&P 500
NYSE
JPM
JP Morgan Chase
AMEX
XLF
Financial Select Sector
FX
USDMXN
US Dollar vs MXN
USOTC
RHHBY
Roche (QX)
COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USI
USTECH100
US Tech 100
NYSE
BAC
Bank of America
AMEX
XLE
Energy Select Sector SPDR
USOTC
BASFY
BASF (QX)
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados